DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

company name or ticker
Company Photos
(Click to zoom)

PRIMECAP Management's New Positions

1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep

Tired of reading through mile-long earnings reports? Have a gander at the one sentence in each of these 10 big pharma earnings reports that tells you everything you need to know about these companies.

Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)

Amgen's Skin Cancer Drug to Face FDA Advisory Panel - Analyst Blog

38.69% Edge To 5 Dow, Highest Yield, Lowest Price, February Stocks With Merck

The Dogs Of The Dow Get Off To A Sluggish Start In 2015

The Dogs of the Dow Get Off to a Sluggish Start in 2015

Comments On Gilead's Quarter And The Road Ahead

XLV, JNJ, PFE, MRK: Large Outflows Detected at ETF

Don't Worry About Orexigen's Obesity Drug EU Approval

Despite what looks initially like bad news for the oral obesity drug, a positive European Commission decision is still likely.
See More Articles...